Hims vs Yucca Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Yucca Health overall, scoring 7.9/10 vs 7.7/10. Yucca Health is more affordable at $146/mo vs $199/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose Yucca Health for cash-pay patients who want a quick 24-hour async approval fo.
A side-by-side comparison of Hims and Yucca Health covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 46One of the largest and most recognized men's telehealth platforms in the US. In 2026 Hims signed a direct partnership with Novo Nordisk adding FDA-approved brand Wegovy (injection and pill) and Ozempic alongside their existing compounded semaglutide program.
Visit HimsYucca Health
#19 of 46Telehealth platform for compounded semaglutide+ and tirzepatide+ with disclosed board-certified prescribers (Dr. Michael Wasef MD and Dr. Andrew Sakla DO), 24-hour asynchronous provider review, UPS 2-Day Air shipping, and integrated buy-now-pay-later financing through Klarna, Affirm, and Afterpay. Pricing is plan-length-tiered: 6-month plan starts at $146/mo for compounded semaglutide and $258/mo for compounded tirzepatide, with monthly pricing higher.
Visit Yucca Health| Feature | Hims | Yucca Health |
|---|---|---|
| Our Score | 7.9/10 | 7.7/10 |
| Starting Price | $199/mo | $146/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand — now with FDA-approved brand access via the 2026 Novo Nordisk partnership | Cash-pay patients who want a quick 24-hour async approval for compounded semaglutide or tirzepatide with disclosed prescribing physicians, UPS 2-Day shipping, and Klarna/Affirm/Afterpay buy-now-pay-later options on longer commitments |
| Ranking | #12 | #19 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Polished app and web experience — one of the best user interfaces in men's telehealth
Cons
- −Brand-name pricing jumps to $599/mo for Wegovy injection — not competitive with LillyDirect/NovoCare cash prices
- −Generic support experience — large patient volume means less personalized attention
- −'Hims Oral Kit' is NOT a GLP-1 (it's a non-GLP-1 combo: metformin + bupropion + topiramate + B12 + naltrexone) — easy to confuse with their compounded semaglutide program
- −Higher price than compounded-only competitors like TrimRx or Enhance MD for the same compounded product
Yucca Health
Pros
- +Two named board-certified prescribers publicly disclosed (Dr. Michael Wasef MD and Dr. Andrew Sakla DO) — rare for the compounded-only tier
- +$146/mo entry price for compounded semaglutide on the 6-month plan is competitive with GobyMeds, Strut, and Mochi at the cheaper end of the market
- +Klarna, Affirm, and Afterpay buy-now-pay-later financing on the 6-month commitments — unique among compounded-only telehealth and useful for spreading the upfront cost
- +24-hour asynchronous provider approval (no live tele-visit required) for users who want fast onboarding without scheduling friction
- +UPS 2-Day Air shipping with secure patient portal, 24/7 support team availability, and welcome onboarding call with a representative
- +Trustpilot 4.4-star rating across 1,000+ reviews and 4.8-star Google rating signal real-world adoption (20,000+ patients reported, 1,000+ enrollments in last 7 days per their site)
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; no oral semaglutide tablet or sublingual format
- −Best pricing requires 6-month commitment (BNPL helps but the discount tier is locked to longer plans — month-to-month is materially higher)
- −No live tele-visit option in the standard intake — purely asynchronous review, which trades clinical depth for speed
- −Founding year, corporate headquarters city, and compounding pharmacy partner names are not publicly disclosed
- −B12 supplementation is not part of the standard formulation (some competitors like PeterMD include it; Yucca markets the products as 'Semaglutide+' and 'Tirzepatide+' but does not specify what the '+' represents)
- −Refund policy referenced on the site but not detailed in public-facing terms — verify before paying for the 6-month plan
Our Verdict
Hims edges out Yucca Health with a score of 7.9/10 vs 7.7/10. If budget is your priority, Yucca Health starts at $146/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand — now with fda-approved brand access via the 2026 novo nordisk partnership. Choose Yucca Health if you want: cash-pay patients who want a quick 24-hour async approval for compounded semaglutide or tirzepatide with disclosed prescribing physicians, ups 2-day shipping, and klarna/affirm/afterpay buy-now-pay-later options on longer commitments.